Your browser doesn't support javascript.
loading
Can an ultrathin strut stent design and a polymer free, proendothelializing probucol matrix coating improve early strut healing? The FRIENDLY-OCT trial. An intra-patient randomized study with OCT, evaluating early strut coverage of a novel probucol coated polymer-free and ultra-thin strut sirolimus-eluting stent compared to a biodegradable polymer sirolimus-eluting stent.
Otaegui Irurueta, Imanol; González Sucarrats, Silvia; Barrón Molina, Jose Luis; Pérez de Prado, Armando; Massotti, Monica; Carmona Ramírez, Maria Ángeles; Martí, Gerard; Bellera, Neus; Serra, Bernat; Serra, Vicenç; Domingo, Enric; López-Benito, María; Sabaté, Manuel; Ferreira González, Ignacio; García Del Blanco, Bruno.
Afiliação
  • Otaegui Irurueta I; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • González Sucarrats S; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain.
  • Barrón Molina JL; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain.
  • Pérez de Prado A; Hospital Universitario de León, León, Spain.
  • Massotti M; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Carmona Ramírez MÁ; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain.
  • Martí G; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Bellera N; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Serra B; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Serra V; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • Domingo E; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • López-Benito M; Hospital Universitario de León, León, Spain.
  • Sabaté M; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Ferreira González I; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Centro de Investigacion Biomedica en Red, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain.
  • García Del Blanco B; Hospital Universitari Vall d'Hebron Barcelona, Barcelona, Spain; Universitat Autónoma de Barcelona, Barcelona, Spain. Electronic address: brunogb51@gmail.com.
Int J Cardiol ; 360: 13-20, 2022 08 01.
Article em En | MEDLINE | ID: mdl-35472561
ABSTRACT

BACKGROUND:

incomplete strut coverage determines the risk of stent thrombosis in the first months after stent implantation.

AIMS:

To evaluate the potential better early healing of a novel probucol coated polymer free ultra-thin strut sirolimus eluting stent (PF-SES). [Clinical trial unique identifier NCT02785237].

METHODS:

Patients with two (angiographically similar) lesions with clinical indication for PCI were enrolled. The investigated stent was compared to a thin strut, bioresorbable polymer, sirolimus eluting stent (BP-SES). Every patient received both stents, one in each lesion, assigned in a randomized sequence. OCT was systematically performed at 3 months. Primary end point was the difference in the proportion of covered struts at 3 months (defined as ≥20 µm of tissue coverage). Secondary end points included differences in percentage of uncovered struts (0 µm coverage), mean strut coverage thickness, and malapposed struts' coverage proportion. Major adverse cardiac events (cardiac death, myocardial infarction, target lesion revascularization, and definite or probable stent thrombosis) at 12 months were also evaluated.

RESULTS:

70 patients were included. At 3 months, a consistent and significantly higher strut coverage rate (≥20 µm) was observed in PF-SES as compared to BP-SES, both for well apposed (87.3% versus 79.1%, p < 0.001) and malapposed struts (50.4% vs 37.8%, p 0.00). Uncoverage rate (0 µm) was also significantly lower for the PF-SES (3.1% vs 5.3%, p < 0.001). There were no differences in clinical endpoints.

CONCLUSION:

The probucol coated non-polymeric ultra-thin strut sirolimus eluting stent showed a significantly better early strut coverage at 3 months.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Stents Farmacológicos / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Cardiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha